Why is Torrent Pharma falling/rising?

As of 15-Sep, Torrent Pharmaceuticals Ltd. is experiencing a decline in its stock price, currently at 3,531.05, which reflects a decrease of 29.0 points or 0.81%. The stock has underperformed its sector by 0.36% today and has been on a consecutive downward trend for the last four days, resulting in a total decline of 2.83% during this period. Despite this recent downturn, the company has shown strong performance over the longer term, with a year-to-date return of 5.23% and a significant 135.40% increase over the last three years. The stock is currently trading above its 100-day and 200-day moving averages but below its 5-day, 20-day, and 50-day moving averages, indicating mixed short-term momentum. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 9.65% compared to the 5-day average.
In the broader market context, the Sensex has gained 1.24% over the past week, contrasting with Torrent Pharmaceuticals' decline of 2.17% during the same period, highlighting a significant underperformance relative to the benchmark. The company's strong fundamentals, including high management efficiency with a return on capital employed (ROCE) of 22.33% and a low debt-to-EBITDA ratio of 1.26, suggest that it has the capacity to weather short-term volatility. Furthermore, the company has consistently reported positive results over the last eight quarters and has high institutional holdings at 24.75%, indicating confidence from knowledgeable investors. However, the recent price movement reflects a combination of short-term selling pressure and reduced trading activity, which may be impacting investor sentiment.